Inflammation-induced fetal growth restriction in rats is associated with increased placental HIF-1α accumulation

• Published in: PloS one 2017-04, Vol.12 (4), p.e0175805-e0175805
• Main Authors: Robb, Kevin P, Cotechini, Tiziana, Allaire, Camille, Sperou, Arissa, Graham, Charles H
• Format: Article
• Language: English
• Subjects: Accumulation; Animals; Biology and Life Sciences; Cytokines; Disease Models, Animal; Female; Fetal Growth Retardation - chemically induced; Fetal Growth Retardation - immunology; Fetal Growth Retardation - pathology; Fetal Growth Retardation - prevention & control; Fetuses; Gene Expression Regulation; Gestational Age; Gynecology; Humans; Hypertension; Hypoxia; Hypoxia - chemically induced; Hypoxia - immunology; Hypoxia - pathology; Hypoxia - prevention & control; Hypoxia-Inducible Factor 1, alpha Subunit - genetics; Hypoxia-Inducible Factor 1, alpha Subunit - immunology; Immunology; Inflammation; Interleukin-10 - genetics; Interleukin-10 - immunology; Interleukin-6 - genetics; Interleukin-6 - immunology; Laboratories; Lipopolysaccharides; Lipopolysaccharides - administration & dosage; Medicine and Health Sciences; Nitric oxide; Nitroglycerin - pharmacology; Obstetrics; Oxygen; Physiology; Placenta; Placenta - drug effects; Placenta - immunology; Placenta - pathology; Pre-Eclampsia - chemically induced; Pre-Eclampsia - immunology; Pre-Eclampsia - pathology; Pre-Eclampsia - prevention & control; Preeclampsia; Pregnancy; Prenatal development; Rats; Rats, Wistar; Rodents; Signal Transduction; Transdermal Patch; Tumor Necrosis Factor-alpha - genetics; Tumor Necrosis Factor-alpha - immunology; Vascular Endothelial Growth Factor Receptor-1 - genetics; Vascular Endothelial Growth Factor Receptor-1 - immunology
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0175805

Hypoxia-inducible factor 1-alpha (HIF-1α) is the oxygen-sensitive subunit of the transcription factor HIF-1, and its expression is increased in placentas from pregnancies complicated by pre-eclampsia (PE). Fetal growth restriction (FGR) and PE often share a common pathophysiology; however, it is unknown whether increased placental HIF-1α occurs in FGR. We previously demonstrated that aberrant maternal inflammation in rats resulted in altered utero-placental perfusion and FGR, both of which were prevented by administration of the nitric oxide mimetic glyceryl trinitrate (GTN). Our aim here was to determine whether abnormal maternal inflammation causing FGR is linked to placental HIF-1α accumulation and whether GTN administration could prevent increases in placental HIF-1α. Levels of inflammatory factors in maternal plasma were measured using a multiplex assay after an injection of low-dose lipopolysaccharide (LPS) to rats on gestational day (GD) 13.5. Following three additional daily LPS injections from GD14.5-16.5, GD17.5 placentas were harvested for HIF-1α immunolocalisation; serial sections were also stained for the hypoxia marker pimonidazole. A subset of rats received LPS injections along with GTN delivered continuously (25 μg/h via a transdermal patch) on GD12.5-GD17.5. Within two hours of LPS administration, levels of maternal pro-inflammatory cytokines were increased compared with saline-treated controls. GD17.5 placentas of growth-restricted fetuses exhibited increased HIF-1α accumulation; however, this did not correlate with pimonidazole staining for which no differences were observed between groups. Furthermore, the LPS-mediated increases in maternal inflammatory cytokine levels and placental HIF-1α accumulation did not occur in rats treated with GTN. Our results demonstrate that inflammation-induced FGR is associated with increased placental HIF-1α accumulation; however, expression of this transcription factor may not correlate with regions of hypoxia in late-gestation placentas. The GTN-mediated attenuation of placental HIF-1α accumulation in LPS-treated rats provides insight into the mechanism by which GTN improves inflammation-induced complications of pregnancy.